Cash flow CVS Health Corporation

Stocks

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - NYSE Other stock markets 00:00:02 18/07/2026 +04			5-day change	1st Jan Change
107.47 ^USD	+0.91%		+3.19%	+35.42%

07-17	CVS Health Opens Pharmacy-Focused Location in Houston	MT
07-17	Cvs Health Unveils First Pharmacy-Focused Cvs Pharmacy Location in Houston	CI

f4e01fe32310fc2ae725b66e44af.u2tVJqAmU_XVZTqsX92xN5AO_s0aoTZwBIE5MbYNCXU.7Ro3UM1xYJOPFnL7L5jYYaJMs4VwlUIxd-lgRIJ4OhbdRmNR7kF-nqE_Dg

Published financial data: CVS HEALTH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	291B	322B	357B	371B	400B
Total Revenues	291B	322B	357B	371B	400B
Cost of Goods Sold, Total	240B	268B	303B	321B	347B
Gross Profit	50.85B	53.46B	53.28B	49.25B	53.13B
Selling General & Admin Expenses, Total	37.07B	38.04B	39.2B	41.23B	43.11B
Other Operating Expenses, Total	37.07B	38.04B	39.2B	41.23B	43.11B
Operating Income	13.78B	15.42B	14.07B	8.02B	10.02B
Interest Expense, Total	-2.5B	-2.29B	-2.66B	-2.96B	-3.12B
Interest And Investment Income	1.2B	838M	1.15B	2.15B	2.23B
Net Interest Expenses	-1.3B	-1.45B	-1.5B	-805M	-886M
Other Non Operating Income (Expenses)	-4M	-4M	-6M	-5M	-5M
EBT, Excl. Unusual Items	12.47B	13.96B	12.56B	7.21B	9.13B
Restructuring Charges	-1.36B	-	-553M	-1.21B	-93M
Merger & Related Restructuring Charges	-132M	-	-487M	-243M	-117M
Impairment of Goodwill	-431M	-	-	-	-5.72B
Gain (Loss) On Sale Of Assets	-	-2.53B	-349M	-	483M
Asset Writedown	-	-	-	-	-
Legal Settlements	263M	-5.8B	-	-100M	-1.54B
Other Unusual Items	-391M	-	-	491M	-
EBT, Incl. Unusual Items	10.42B	5.63B	11.17B	6.15B	2.14B
Income Tax Expense	2.52B	1.46B	2.8B	1.56B	408M
Earnings From Continuing Operations	7.9B	4.16B	8.37B	4.59B	1.73B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	7.9B	4.16B	8.37B	4.59B	1.73B
Minority Interest	12M	-16M	-24M	28M	40M
Net Income - (IS)	7.91B	4.15B	8.34B	4.61B	1.77B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	7.91B	4.15B	8.34B	4.61B	1.77B
Net Income to Common Excl. Extra Items	7.91B	4.15B	8.34B	4.61B	1.77B
Per Share Items
Net EPS - Basic	6	3.16	6.49	3.66	1.4
Basic EPS - Continuing Operations	6	3.16	6.49	3.66	1.4
Basic Weighted Average Shares Outstanding	1.32B	1.31B	1.28B	1.26B	1.27B
Net EPS - Diluted	5.95	3.14	6.47	3.66	1.39
Diluted EPS - Continuing Operations	5.95	3.14	6.47	3.66	1.39
Diluted Weighted Average Shares Outstanding	1.33B	1.32B	1.29B	1.26B	1.27B
Normalized Basic EPS	5.92	6.64	6.09	3.6	4.53
Normalized Diluted EPS	5.87	6.58	6.07	3.59	4.52
Dividend Per Share	2	2.2	2.42	2.66	2.66
Payout Ratio	33.19	70.06	37.54	73.1	192.14
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	18.29B	19.66B	18.44B	12.62B	14.62B
EBITA	16.04B	17.22B	15.98B	10.04B	12B
EBIT	13.78B	15.42B	14.07B	8.02B	10.02B
EBITDAR	21.5B	22.82B	21.56B	15.64B	17.64B
Total Revenues (As Reported)	292B	322B	358B	373B	402B
Effective Tax Rate - (Ratio)	24.2	26	25.11	25.41	19.1
Current Domestic Taxes	2.95B	3.54B	3.48B	2.13B	192M
Current Foreign Taxes	-	-	-	-	114M
Total Current Taxes	2.95B	3.54B	3.48B	2.13B	306M
Deferred Domestic Taxes	-428M	-2.08B	-676M	-572M	102M
Total Deferred Taxes	-428M	-2.08B	-676M	-572M	102M
Normalized Net Income	7.81B	8.71B	7.83B	4.53B	5.74B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	2.54B	2.29B	73M	71M	69M
Non-Cash Pension Expense	-186M	-173M	-94M	-104M	-117M
Supplemental Operating Expense Items
Advertising Expense	523M	745M	985M	989M	970M
Selling and Marketing Expenses	523M	745M	985M	989M	970M
Net Rental Expense, Total	3.21B	3.16B	3.13B	3.02B	3.02B
Imputed Operating Lease Interest Expense	798M	787M	886M	882M	924M
Imputed Operating Lease Depreciation	2.41B	2.37B	2.24B	2.14B	2.09B
Stock-Based Comp., Other (Total)	484M	447M	588M	540M	535M
Total Stock-Based Compensation	484M	447M	588M	540M	535M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9.41B	12.94B	8.2B	8.59B	8.45B
Short Term Investments	3.12B	2.78B	3.26B	2.41B	2.14B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	12.52B	15.72B	11.46B	10.99B	10.6B
Accounts Receivable, Total	21.04B	23.83B	15.62B	14.61B	16.32B
Other Receivables	3.39B	3.45B	19.6B	21.86B	23.46B
Total Receivables	24.43B	27.28B	35.23B	36.47B	39.78B
Inventory	17.76B	19.09B	18.02B	18.11B	19.25B
Restricted Cash	3.06B	144M	90M	95M	59M
Other Current Assets, Total	2.23B	3.45B	3.06B	2.98B	5.03B
Total Current Assets	60.01B	65.68B	67.86B	68.64B	74.71B
Gross Property Plant And Equipment	52.67B	52.23B	51.13B	52.38B	52.8B
Accumulated Depreciation	-20.65B	-21.48B	-20.7B	-23.45B	-24.74B
Net Property Plant And Equipment	32.02B	30.74B	30.44B	28.94B	28.06B
Long-term Investments	23.02B	21.1B	23.02B	28.93B	32.67B
Goodwill	79.12B	78.15B	91.27B	91.27B	85.48B
Other Intangibles, Total	29.03B	24.75B	29.23B	27.32B	25.51B
Other Long-Term Assets, Total	9.8B	7.85B	7.91B	8.1B	7.11B
Total Assets	233B	228B	250B	253B	254B
Liabilities
Accounts Payable, Total	12.54B	14.84B	14.9B	15.89B	17.64B
Accrued Expenses, Total	25.29B	29.08B	33.94B	35.73B	37.72B
Short-term Borrowings	-	-	200M	2.12B	-
Current Portion of Long-Term Debt	4.16B	1.72B	2.71B	3.56B	4.01B
Current Portion of Leases	1.7B	1.74B	1.81B	1.82B	1.8B
Unearned Revenue Current, Total	87M	71M	149M	144M	62M
Other Current Liabilities	24.03B	22.29B	25.49B	25.35B	27.46B
Total Current Liabilities	67.81B	69.74B	79.19B	84.61B	88.69B
Long-Term Debt	50.72B	49.07B	57.31B	59.23B	59.24B
Long-Term Leases	19.43B	18.21B	17.36B	16.19B	14.91B
Pension & Other Post Retirement Benefits	250M	197M	189M	169M	165M
Deferred Tax Liability Non Current	6.27B	3.88B	4.31B	3.81B	3.83B
Other Non Current Liabilities	13.14B	15.87B	14.73B	13.48B	11.32B
Total Liabilities	158B	157B	173B	177B	178B
Common Stock, Total	17M	18M	18M	18M	18M
Additional Paid In Capital	47.36B	48.18B	48.97B	49.64B	50.38B
Retained Earnings	54.91B	56.14B	61.6B	62.84B	61.2B
Treasury Stock	-28.14B	-31.83B	-33.81B	-36.82B	-36.79B
Comprehensive Income and Other	936M	-1.49B	-326M	-120M	406M
Total Common Equity	75.08B	71.02B	76.46B	75.56B	75.21B
Minority Interest	306M	300M	175M	170M	168M
Total Equity	75.38B	71.32B	76.64B	75.73B	75.38B
Total Liabilities And Equity	233B	228B	250B	253B	254B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.31B	1.28B	1.26B	1.26B	1.27B
ECS Total Common Shares Outstanding	1.32B	1.3B	1.29B	1.26B	1.27B
Book Value / Share	56.79	54.63	59.36	59.97	59.18
Tangible Book Value	-33.07B	-31.89B	-44.04B	-43.04B	-35.77B
Tangible Book Value Per Share	-25.02	-24.53	-34.2	-34.15	-28.14
Total Debt	76B	70.73B	79.38B	82.92B	79.95B
Net Debt	63.47B	55.01B	67.93B	71.93B	69.35B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-668M	-606M	-643M	-839M	-950M
Debt Equivalent Oper. Leases	25.66B	25.24B	25.01B	24.19B	24.13B
Minority Interest, Total (Incl. Fin. Div)	306M	300M	175M	170M	168M
Account Code - Inventory Valuation	6	6	6	6	6
Land - (BS)	2.04B	2B	1.96B	1.85B	1.81B
Buildings, Total	4.22B	4.54B	4.57B	4.63B	4.59B
Machinery, Total	13.62B	12.73B	11.02B	11.72B	11.74B
Full Time Employees	216K	219K	219K	219K	219K
Part Time Employees	84K	81K	81K	81K	81K
Accumulated Allowance for Doubtful Accounts (Supple)	339M	333M	343M	407M	182M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	7.91B	4.15B	8.34B	4.61B	1.77B
Depreciation & Amortization - CF	2.25B	2.44B	2.46B	2.57B	2.63B
Amortization of Goodwill and Intangible Assets - (CF)	2.26B	1.81B	1.9B	2.02B	1.98B
Depreciation & Amortization, Total	4.51B	4.25B	4.37B	4.6B	4.61B
(Gain) Loss From Sale Of Asset	-	2.06B	349M	-	-247M
Asset Writedown & Restructuring Costs	1.79B	-	-	840M	5.72B
Stock-Based Compensation (CF)	484M	447M	588M	540M	535M
Other Operating Activities, Total	-378M	-1.73B	-236M	-1.59B	-274M
Change In Accounts Receivable	-2.7B	-2.97B	-6.26B	-1.3B	-3.5B
Change In Inventories	735M	-1.44B	1.23B	-102M	-1.27B
Change In Accounts Payable	2.9B	4.26B	3.62B	2.34B	3.86B
Change in Other Net Operating Assets	3.02B	7.15B	1.42B	-823M	-564M
Cash from Operations	18.26B	16.18B	13.43B	9.11B	10.64B
Capital Expenditure	-2.52B	-2.73B	-3.03B	-2.78B	-2.83B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-146M	-139M	-16.61B	-95M	-436M
Divestitures	-	-1.25B	-	-	-
Investment in Marketable and Equity Securities, Total	-2.72B	-1.02B	-1.31B	-4.84B	-2.63B
Other Investing Activities, Total	122M	85M	68M	101M	26M
Cash from Investing	-5.26B	-5.05B	-20.89B	-7.61B	-5.87B
Short Term Debt Issued, Total	-	-	5.2B	1.92B	-
Long-Term Debt Issued, Total	987M	-	10.9B	7.91B	3.97B
Total Debt Issued	987M	-	16.1B	9.83B	3.97B
Short Term Debt Repaid, Total	-	-	-5B	-	-2.12B
Long-Term Debt Repaid, Total	-10.25B	-4.21B	-3.17B	-4.77B	-3.63B
Total Debt Repaid	-10.25B	-4.21B	-8.17B	-4.77B	-5.75B
Issuance of Common Stock	549M	551M	277M	361M	394M
Repurchase of Common Stock	-168M	-3.87B	-2.19B	-3.21B	-158M
Common Dividends Paid	-2.62B	-2.91B	-3.13B	-3.37B	-3.4B
Common & Preferred Stock Dividends Paid	-2.62B	-2.91B	-3.13B	-3.37B	-3.4B
Other Financing Activities, Total	155M	-79M	-201M	26M	-
Cash from Financing	-11.36B	-10.52B	2.68B	-1.14B	-4.94B
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	1.65B	614M	-4.78B	359M	-172M
Supplemental Items
Cash Interest Paid	2.47B	2.24B	2.42B	2.91B	2.99B
Cash Income Tax Paid (Refund)	3.2B	4.12B	3.52B	1.7B	2.17B
Levered Free Cash Flow	14.57B	12.02B	11.08B	6.91B	5.93B
Unlevered Free Cash Flow	16.14B	13.45B	12.74B	8.76B	7.88B
Change In Net Working Capital	-5.05B	-1.85B	-2.02B	-1.39B	692M
Net Debt Issued / Repaid	-9.27B	-4.21B	7.93B	5.06B	-1.78B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.71	4.18	3.68	1.99	2.47
Return on Total Capital	5.63	6.57	5.89	3.19	3.99
Return On Equity %	10.89	5.68	11.28	6.02	2.29
Return on Common Equity	10.95	5.68	11.28	6.07	2.35
Margin Analysis
Gross Profit Margin %	17.48	16.62	14.94	13.29	13.29
SG&A Margin	12.74	11.83	10.99	11.12	10.78
EBITDA Margin %	6.29	6.11	5.17	3.4	3.66
EBITA Margin %	5.51	5.36	4.48	2.71	3
EBIT Margin %	4.74	4.79	3.95	2.16	2.51
Income From Continuing Operations Margin %	2.71	1.29	2.35	1.24	0.43
Net Income Margin %	2.72	1.29	2.34	1.24	0.44
Net Avail. For Common Margin %	2.72	1.29	2.34	1.24	0.44
Normalized Net Income Margin	2.68	2.71	2.19	1.22	1.44
Levered Free Cash Flow Margin	5.01	3.74	3.11	1.86	1.48
Unlevered Free Cash Flow Margin	5.55	4.18	3.57	2.36	1.97
Asset Turnover
Asset Turnover	1.25	1.39	1.49	1.47	1.58
Fixed Assets Turnover	8.9	10.25	11.66	12.49	14.03
Receivables Turnover (Average Receivables)	14.34	14.34	16.63	24.52	25.86
Inventory Turnover (Average Inventory)	13.24	14.55	16.35	17.79	18.56
Short Term Liquidity
Current Ratio	0.88	0.94	0.86	0.81	0.84
Quick Ratio	0.55	0.62	0.59	0.56	0.57
Operating Cash Flow to Current Liabilities	0.27	0.23	0.17	0.11	0.12
Days Sales Outstanding (Average Receivables)	25.46	25.46	21.95	14.93	14.12
Days Outstanding Inventory (Average Inventory)	27.56	25.08	22.33	20.57	19.66
Average Days Payable Outstanding	18.06	18.54	17.95	17.53	17.59
Cash Conversion Cycle (Average Days)	34.96	31.99	26.33	17.97	16.19
Long Term Solvency
Total Debt/Equity	100.82	99.18	103.59	109.49	106.06
Total Debt / Total Capital	50.2	49.79	50.88	52.27	51.47
LT Debt/Equity	93.06	94.34	97.44	99.6	98.36
Long-Term Debt / Total Capital	46.34	47.36	47.86	47.54	47.73
Total Liabilities / Total Assets	67.65	68.76	69.31	70.09	70.27
EBIT / Interest Expense	5.5	6.74	5.29	2.71	3.21
EBITDA / Interest Expense	8.59	9.98	8.11	5.29	5.66
(EBITDA - Capex) / Interest Expense	7.58	8.79	6.97	4.35	4.75
Total Debt / EBITDA	3.54	3.1	3.68	5.3	4.53
Net Debt / EBITDA	2.95	2.41	3.15	4.6	3.93
Total Debt / (EBITDA - Capex)	4.01	3.52	4.28	6.45	5.4
Net Debt / (EBITDA - Capex)	3.34	2.74	3.67	5.59	4.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.59	10.56	10.88	3.93	7.87
Gross Profit, 1 Yr. Growth %	5.39	5.13	-0.72	-7.56	7.88
EBITDA, 1 Yr. Growth %	1.02	5.99	-7.65	-31.58	15.92
EBITA, 1 Yr. Growth %	0.2	5.68	-8.84	-37.14	19.42
EBIT, 1 Yr. Growth %	0.83	9.81	-10.6	-43.02	24.94
Earnings From Cont. Operations, 1 Yr. Growth %	9.68	-47.27	93.39	-45.2	-62.32
Net Income, 1 Yr. Growth %	10.18	-47.55	93.55	-44.7	-61.68
Normalized Net Income, 1 Yr. Growth %	8.39	9.31	-12.2	-42.08	26.72
Diluted EPS Before Extra, 1 Yr. Growth %	8.78	-47.23	98.47	-43.43	-62.02
Accounts Receivable, 1 Yr. Growth %	7.66	13.24	-42.73	-6.47	11.66
Inventory, 1 Yr. Growth %	-3.98	7.49	-5.58	0.45	6.29
Net Property, Plant and Equip., 1 Yr. Growth %	-3.95	-3.98	-1.01	-4.92	-3.04
Total Assets, 1 Yr. Growth %	0.99	-2.03	9.4	1.4	0.13
Tangible Book Value, 1 Yr. Growth %	-19.93	-3.58	39.9	-2.29	-16.88
Common Equity, 1 Yr. Growth %	8.19	-5.41	6.98	-1.18	-0.46
Cash From Operations, 1 Yr. Growth %	15.13	-11.43	-17.01	-32.17	16.82
Capital Expenditures, 1 Yr. Growth %	3.41	8.21	11.15	-8.25	1.83
Levered Free Cash Flow, 1 Yr. Growth %	13.21	-18.42	-7.21	-37.62	-14.18
Unlevered Free Cash Flow, 1 Yr. Growth %	9.86	-17.48	-4.7	-31.24	-10.04
Dividend Per Share, 1 Yr. Growth %	0	10	10	9.92	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.65	9.57	10.72	7.35	5.89
Gross Profit, 2 Yr. CAGR %	6.88	5.26	2.29	-4.2	-0.14
EBITDA, 2 Yr. CAGR %	6.29	4.22	-0.55	-20.51	-10.94
EBITA, 2 Yr. CAGR %	6.07	3.74	-1.26	-24.3	-13.36
EBIT, 2 Yr. CAGR %	7.97	6.22	-0.3	-28.63	-15.62
Earnings From Cont. Operations, 2 Yr. CAGR %	9.14	-23.95	2.34	2.95	-54.56
Net Income, 2 Yr. CAGR %	9.19	-23.98	2.12	3.45	-53.97
Normalized Net Income, 2 Yr. CAGR %	12.93	9.99	-1.35	-28.69	-14.33
Diluted EPS Before Extra, 2 Yr. CAGR %	8.22	-24.23	3.67	5.96	-53.65
Accounts Receivable, 2 Yr. CAGR %	10.49	10.41	-13.84	-26.81	2.2
Inventory, 2 Yr. CAGR %	0.69	1.59	0.74	-2.61	3.33
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.36	-3.96	-2.5	-2.98	-3.99
Total Assets, 2 Yr. CAGR %	2.34	-0.53	3.53	5.32	0.76
Tangible Book Value, 2 Yr. CAGR %	-17.85	-12.13	15.4	16.91	-9.88
Common Equity, 2 Yr. CAGR %	8.42	1.16	0.92	2.82	-0.82
Cash From Operations, 2 Yr. CAGR %	19.23	0.98	-14.26	-24.97	-10.98
Capital Expenditures, 2 Yr. CAGR %	1.27	5.78	9.67	0.99	-3.34
Levered Free Cash Flow, 2 Yr. CAGR %	19.67	-3.36	-13.44	-23.92	-26.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	15.62	-4.3	-11.73	-19.05	-21.35
Dividend Per Share, 2 Yr. CAGR %	0	4.88	10	9.96	4.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.48	7.94	10	8.41	7.52
Gross Profit, 3 Yr. CAGR %	18.09	6.29	3.36	-1.11	-0.33
EBITDA, 3 Yr. CAGR %	12.72	6.7	0.61	-12.21	-9.86
EBITA, 3 Yr. CAGR %	13.19	6.51	-0.05	-15.06	-11.88
EBIT, 3 Yr. CAGR %	11.08	9.27	0.99	-17.26	-13.98
Earnings From Cont. Operations, 3 Yr. CAGR %	136.64	-14.36	5.13	-16.89	-26.36
Net Income, 3 Yr. CAGR %	137.03	-14.48	5.14	-16.76	-25.7
Normalized Net Income, 3 Yr. CAGR %	15.56	12.49	2.82	-17.39	-13.62
Diluted EPS Before Extra, 3 Yr. CAGR %	118.31	-14.82	5.76	-15.28	-24.73
Accounts Receivable, 3 Yr. CAGR %	9.4	11.4	-7.19	-11.45	-15.74
Inventory, 3 Yr. CAGR %	2.59	2.91	-0.86	0.65	0.27
Net Property, Plant and Equip., 3 Yr. CAGR %	41.3	-2.24	-2.99	-3.32	-3
Total Assets, 3 Yr. CAGR %	5.85	0.87	2.67	2.81	3.56
Tangible Book Value, 3 Yr. CAGR %	-16.58	-13.34	2.16	9.17	4.35
Common Equity, 3 Yr. CAGR %	8.84	3.6	3.29	0.21	1.72
Cash From Operations, 3 Yr. CAGR %	27.25	7.98	-5.41	-20.7	-13.04
Capital Expenditures, 3 Yr. CAGR %	7.35	3.54	7.54	3.34	1.27
Levered Free Cash Flow, 3 Yr. CAGR %	5.02	5.72	-4.88	-22.4	-20.8
Unlevered Free Cash Flow, 3 Yr. CAGR %	4.31	3.67	-4.64	-18.78	-16.15
Dividend Per Share, 3 Yr. CAGR %	0	3.23	6.56	9.97	6.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.38	11.72	12.96	7.7	8.34
Gross Profit, 5 Yr. CAGR %	11.99	13.4	11.53	2.04	1.95
EBITDA, 5 Yr. CAGR %	6.98	9.93	7.63	-4.86	-4.18
EBITA, 5 Yr. CAGR %	7.12	10.22	7.64	-6.76	-5.6
EBIT, 5 Yr. CAGR %	5.43	9.55	6.96	-7.46	-6.02
Earnings From Cont. Operations, 5 Yr. CAGR %	8.22	-8.88	69.62	-7.11	-24.83
Net Income, 5 Yr. CAGR %	8.27	-8.93	69.64	-7	-24.44
Normalized Net Income, 5 Yr. CAGR %	5.59	9.82	9.12	-5.82	-4.42
Diluted EPS Before Extra, 5 Yr. CAGR %	3.92	-13.41	62.45	-6.35	-23.97
Accounts Receivable, 5 Yr. CAGR %	11.58	12.82	-0.57	-3.25	-3.55
Inventory, 5 Yr. CAGR %	3.77	4.53	1.85	0.67	0.8
Net Property, Plant and Equip., 5 Yr. CAGR %	25.77	24.47	21.81	-2.54	-3.39
Total Assets, 5 Yr. CAGR %	19.79	19.13	4.92	2.62	1.9
Tangible Book Value, 5 Yr. CAGR %	17.24	17.25	-5.02	-2.57	-2.84
Common Equity, 5 Yr. CAGR %	15.31	13.51	5.6	3.42	1.63
Cash From Operations, 5 Yr. CAGR %	12.49	15.1	8.66	-6.65	-7.68
Capital Expenditures, 5 Yr. CAGR %	2.53	7.29	8.27	2.51	3.05
Levered Free Cash Flow, 5 Yr. CAGR %	13.32	15.4	-2.52	-7.45	-14.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	13.75	15.52	-2.18	-6.22	-11.71
Dividend Per Share, 5 Yr. CAGR %	3.3	1.92	3.89	5.87	5.87